Contents

S-14671

Chemical compound

This article may be too technical for most readers to understand. Please help improve ittomake it understandable to non-experts, without removing the technical details. (September 2013) (Learn how and when to remove this message)

S-14671

Clinical data
ATC code	none
Identifiers
IUPAC name N-{2-[4-(7-methoxynaphthalen-1-yl)piperazin-1-yl]ethyl}thiophene-2-carboxamide
CAS Number	135722-27-9
PubChem CID	131907
IUPHAR/BPS	25
ChemSpider	116529
CompTox Dashboard (EPA)	DTXSID60159503
Chemical and physical data
Formula	C22H25N3O2S
Molar mass	395.52 g·mol−1

S-14671 is a naphthylpiperazine derivative which acts as a 5-HT_1A receptor agonist (pK_i = 9.3) with high efficacy and exceptional in vivo potency, and also as a 5-HT_2A and 5-HT_2C receptor antagonist (both are pK_i = 7.8).^[1][2] It displays only low and non-significant affinity for 5-HT_1B and 5-HT₃ sites.^[2]

In producing 5-HT_1A-mediated effects such as hypothermia and spontaneous tail flicks in rodents, S-14671 is activeatdoses as low as 5 μg subcutaneously, and is about 10-fold more potent than 8-OH-DPAT and 100-fold more potent than flesinoxan and buspirone.^[1][2] Other 5-HT_1A-mediated effects of S-14671 include induction of flat-body posture, corticosterone secretion, inhibition of morphine-induced antinociception, and attenuation of the electrical activity of the dorsal raphe nucleus.^[2]

S-14671 has been found to possess powerful efficacy in the rodent forced swim test and in the pigeon conflict test, indicating marked antidepressant and anxiolytic effects, respectively, of which are also 5-HT_1A-mediated.^[3][4] It has never been trialed in humans, perhaps due to its potency being too great.^{[citation needed]}

See also[edit]

• CSP-2503
• Naphthylpiperazine

References[edit]